Transforming Growth Factor Beta Receptor 2 (TGFBR2) Changes Sialylation in the Microsatellite Unstable (MSI) Colorectal Cancer Cell Line HCT116

PLoS ONE

Volumn 8, Issue 2, 2013, Pages

  Lee, Jennifer ^a,b   Ballikaya, Seda ^a,b   Schönig, Kai ^c   Ball, Claudia R ^b   Glimm, Hanno ^b   Kopitz, Juergen ^a,b   Gebert, Johannes ^a,b  

^a UNIVERSITY HOSPITAL HEIDELBERG   (Germany)

^b GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

^c MEDICAL FACULTY MANNHEIM HEIDELBERG UNIVERSITY   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

BETA1 INTEGRIN; DOXYCYCLINE; MANNOSAMINE; SIALOGLYCOPROTEIN; SIALYLTRANSFERASE; TRANSFORMING GROWTH FACTOR BETA RECEPTOR 2;

ARTICLE; CARBOHYDRATE SYNTHESIS; CARCINOMA CELL; COLORECTAL CARCINOMA; CONTROLLED STUDY; GENE CASSETTE; GENE DOSAGE; GENE EXPRESSION REGULATION; GENETIC RECOMBINATION; MICROSATELLITE INSTABILITY; MOLECULAR CLONING; NONHUMAN; PROTEIN METABOLISM; SIALYLATION; SIGNAL TRANSDUCTION; TRANSFORMING GROWTH FACTOR BETA RECEPTOR 2 GENE; TRANSGENE; WILD TYPE;

ANTIGENS, CD29; BASE SEQUENCE; COLORECTAL NEOPLASMS; DOXYCYCLINE; GENE EXPRESSION REGULATION; GENE ORDER; GENE TARGETING; GENOMIC INSTABILITY; HCT116 CELLS; HUMANS; MICROSATELLITE REPEATS; POLYSACCHARIDES; PROTEIN-SERINE-THREONINE KINASES; RECEPTORS, TRANSFORMING GROWTH FACTOR BETA;

EID: 84874508899     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0057074     Document Type: Article

References (60)

1. Lawes DA, SenGupta S, Boulos PB, (2003) The clinical importance and prognostic implications of microsatellite instability in sporadic cancer. Eur J Surg Oncol 29: 201-212.
2. Royrvik EC, Ahlquist T, Rognes T, Lothe RA, (2007) Slip slidin' away: a duodecennial review of targeted genes in mismatch repair deficient colorectal cancer. Crit Rev Oncog 13: 229-257.
3. Thibodeau SN, Bren G, Schaid D, (1993) Microsatellite instability in cancer of the proximal colon. Science 260: 816-819.
4. Woerner SM, Gebert J, Yuan YP, Sutter C, Ridder R, et al. (2001) Systematic identification of genes with coding microsatellites mutated in DNA mismatch repair-deficient cancer cells. International Journal of Cancer 93: 12-19.
5. Mori Y, Yin J, Rashid A, Leggett BA, Young J, et al. (2001) Instabilotyping: comprehensive identification of frameshift mutations caused by coding region microsatellite instability. Cancer Research 61: 6046-6049.
6. Duval A, Hamelin R, (2002) Mutations at coding repeat sequences in mismatch repair-deficient human cancers: toward a new concept of target genes for instability. Cancer Research 62: 2447-2454.
7. Woerner SM, Benner A, Sutter C, Schiller M, Yuan YP, et al. (2003) Pathogenesis of DNA repair-deficient cancers: a statistical meta-analysis of putative Real Common Target genes. Oncogene 22: 2226-2235.
8. Markowitz S, Wang J, Myeroff L, Parsons R, Sun L, et al. (1995) Inactivation of the type II TGF-beta receptor in colon cancer cells with microsatellite instability. Science 268: 1336-1338.
9. Kim SJ, Im YH, Markowitz SD, Bang YJ, (2000) Molecular mechanisms of inactivation of TGF-beta receptors during carcinogenesis. Cytokine Growth Factor Rev 11: 159-168.
10. Markowitz SD, Roberts AB, (1996) Tumor suppressor activity of the TGF-beta pathway in human cancers. Cytokine Growth Factor Rev 7: 93-102.
11. Fynan TM, Reiss M, (1993) Resistance to inhibition of cell growth by transforming growth factor-beta and its role in oncogenesis. Crit Rev Oncog 4: 493-540.
12. Massague J, (1996) TGFbeta signaling: receptors, transducers, and Mad proteins. Cell 85: 947-950.
13. Nakao A, Afrakhte M, Moren A, Nakayama T, Christian JL, et al. (1997) Identification of Smad7, a TGFbeta-inducible antagonist of TGF-beta signalling. Nature 389: 631-635.
14. Hua X, Miller ZA, Wu G, Shi Y, Lodish HF, (1999) Specificity in transforming growth factor beta-induced transcription of the plasminogen activator inhibitor-1 gene: interactions of promoter DNA, transcription factor muE3, and Smad proteins. Proc Natl Acad Sci U S A 96: 13130-13135.
15. Geng Y, Marshall JR, King MR, (2012) Glycomechanics of the metastatic cascade: tumor cell-endothelial cell interactions in the circulation. Ann Biomed Eng 40: 790-805.
16. Dall'Olio F, Malagolini N, Trinchera M, Chiricolo M, (2012) Mechanisms of cancer-associated glycosylation changes. Front Biosci 17: 670-699.
17. Gabius HJ (2009) Chapter 25 Glycans as Functional Markers in Malignancy? In: Gabius HJ, editor. The Sugar Code. Weinheim, Germany: Wiley-VCH. pp. 419-432.
18. Petretti T, Kemmner W, Schulze B, Schlag PM, (2000) Altered mRNA expression of glycosyltransferases in human colorectal carcinomas and liver metastases. Gut 46: 359-366.
19. Ito H, Hiraiwa N, Sawada-Kasugai M, Akamatsu S, Tachikawa T, et al. (1997) Altered mRNA expression of specific molecular species of fucosyl- and sialyl-transferases in human colorectal cancer tissues. International Journal of Cancer 71: 556-564.
20. Kemmner W, Roefzaad C, Haensch W, Schlag PM, (2003) Glycosyltransferase expression in human colonic tissue examined by oligonucleotide arrays. Biochim Biophys Acta 1621: 272-279.
21. Natsuka S, Gersten KM, Zenita K, Kannagi R, Lowe JB, (1994) Molecular cloning of a cDNA encoding a novel human leukocyte alpha-1,3-fucosyltransferase capable of synthesizing the sialyl Lewis x determinant. J Biol Chem 269: 20806.
22. Yogeeswaran G, Salk PL, (1981) Metastatic potential is positively correlated with cell surface sialylation of cultured murine tumor cell lines. Science 212: 1514-1516.
23. Altevogt P, Fogel M, Cheingsong-Popov R, Dennis J, Robinson P, et al. (1983) Different patterns of lectin binding and cell surface sialylation detected on related high- and low-metastatic tumor lines. Cancer Research 43: 5138-5144.
24. Morgenthaler J, Kemmner W, Brossmer R, (1990) Sialic acid dependent cell adhesion to collagen IV correlates with in vivo tumorigenicity of the human colon carcinoma sublines HCT116, HCT116a and HCT116b. Biochemical and Biophysical Research Communications 171: 860-866.
25. Guo HB, Lee I, Kamar M, Akiyama SK, Pierce M, (2002) Aberrant N-glycosylation of beta1 integrin causes reduced alpha5beta1 integrin clustering and stimulates cell migration. Cancer Research 62: 6837-6845.
26. Janik ME, Litynska A, Vereecken P, (2010) Cell migration-the role of integrin glycosylation. Biochim Biophys Acta 1800: 545-555.
27. Seales EC, Jurado GA, Brunson BA, Wakefield JK, Frost AR, et al. (2005) Hypersialylation of beta1 integrins, observed in colon adenocarcinoma, may contribute to cancer progression by up-regulating cell motility. Cancer Research 65: 4645-4652.
28. Semel AC, Seales EC, Singhal A, Eklund EA, Colley KJ, et al. (2002) Hyposialylation of integrins stimulates the activity of myeloid fibronectin receptors. J Biol Chem 277: 32830-32836.
29. Seales EC, Jurado GA, Singhal A, Bellis SL, (2003) Ras oncogene directs expression of a differentially sialylated, functionally altered beta1 integrin. Oncogene 22: 7137-7145.
30. Patsos G, Andre S, Roeckel N, Gromes R, Gebert J, et al. (2009) Compensation of loss of protein function in microsatellite-unstable colon cancer cells (HCT116): a gene-dependent effect on the cell surface glycan profile. Glycobiology 19: 726-734.
31. Weidenfeld I, Gossen M, Low R, Kentner D, Berger S, et al. (2009) Inducible expression of coding and inhibitory RNAs from retargetable genomic loci. Nucleic Acids Research 37: e50.
32. Schlake T, Bode J, (1994) Use of mutated FLP recognition target (FRT) sites for the exchange of expression cassettes at defined chromosomal loci. Biochemistry 33: 12746-12751.
33. Welman A, Barraclough J, Dive C, (2006) Generation of cells expressing improved doxycycline-regulated reverse transcriptional transactivator rtTA2S-M2. Nature Protocols 1: 803-811.
34. Soneoka Y, Cannon PM, Ramsdale EE, Griffiths JC, Romano G, et al. (1995) A transient three-plasmid expression system for the production of high titer retroviral vectors. Nucleic Acids Research 23: 628-633.
35. Loew R, Vigna E, Lindemann D, Naldini L, Bujard H, (2006) Retroviral vectors containing Tet-controlled bidirectional transcription units for simultaneous regulation of two gene activities. J Mol Genet Med 2: 107-118.
36. Paruzynski A, Arens A, Gabriel R, Bartholomae CC, Scholz S, et al. (2010) Genome-wide high-throughput integrome analyses by nrLAM-PCR and next-generation sequencing. Nature Protocols 5: 1379-1395.
37. Kent WJ, (2002) BLAT--the BLAST-like alignment tool. Genome Research 12: 656-664.
38. Heino J, Ignotz RA, Hemler ME, Crouse C, Massague J, (1989) Regulation of cell adhesion receptors by transforming growth factor-beta. Concomitant regulation of integrins that share a common beta 1 subunit. J Biol Chem 264: 380-388.
39. Adamczyk B, Tharmalingam T, Rudd PM, (2012) Glycans as cancer biomarkers. Biochim Biophys Acta 1820: 1347-1353.
40. Schultz MJ, Swindall AF, Bellis SL, (2012) Regulation of the metastatic cell phenotype by sialylated glycans. Cancer Metastasis Rev 31: 501-518.
41. Swindall AF, Bellis SL, (2011) Sialylation of the Fas death receptor by ST6Gal-I provides protection against Fas-mediated apoptosis in colon carcinoma cells. J Biol Chem 286: 22982-22990.
42. Park JJ, Yi JY, Jin YB, Lee YJ, Lee JS, et al. (2012) Sialylation of epidermal growth factor receptor regulates receptor activity and chemosensitivity to gefitinib in colon cancer cells. Biochem Pharmacol 83: 849-857.
43. Zhuo Y, Chammas R, Bellis SL, (2008) Sialylation of beta1 integrins blocks cell adhesion to galectin-3 and protects cells against galectin-3-induced apoptosis. J Biol Chem 283: 22177-22185.
44. Ignotz RA, Heino J, Massague J, (1989) Regulation of cell adhesion receptors by transforming growth factor-beta. Regulation of vitronectin receptor and LFA-1. J Biol Chem 264: 389-392.
45. Bellis SL, Newman E, Friedman EA, (1999) Steps in integrin beta1-chain glycosylation mediated by TGFbeta1 signaling through Ras. Journal of Cellular Physiology 181: 33-44.
46. Dall'Olio F, Chiricolo M, Lau JT, (1999) Differential expression of the hepatic transcript of beta-galactoside alpha2,6-sialyltransferase in human colon cancer cell lines. International Journal of Cancer 81: 243-247.
47. Ma J, Simonovic M, Qian R, Colley KJ, (1999) Sialyltransferase isoforms are phosphorylated in the cis-medial Golgi on serine and threonine residues in their luminal sequences. J Biol Chem 274: 8046-8052.
48. Kawamura YI, Kawashima R, Fukunaga R, Hirai K, Toyama-Sorimachi N, et al. (2005) Introduction of Sd(a) carbohydrate antigen in gastrointestinal cancer cells eliminates selectin ligands and inhibits metastasis. Cancer Research 65: 6220-6227.
49. Malagolini N, Santini D, Chiricolo M, Dall'Olio F, (2007) Biosynthesis and expression of the Sda and sialyl Lewis x antigens in normal and cancer colon. Glycobiology 17: 688-697.
50. Costa-Nogueira C, Villar-Portela S, Cuevas E, Gil-Martin E, Fernandez-Briera A, (2009) Synthesis and expression of CDw75 antigen in human colorectal cancer. BMC Cancer 9: 431.
51. Berns A, (2008) Kras and Hras--what is the difference? Nat Genet 40: 1149-1150.
52. Matallanas D, Arozarena I, Berciano MT, Aaronson DS, Pellicer A, et al. (2003) Differences on the inhibitory specificities of H-Ras, K-Ras, and N-Ras (N17) dominant negative mutants are related to their membrane microlocalization. J Biol Chem 278: 4572-4581.
53. Hsu LJ, Schultz L, Hong Q, Van Moer K, Heath J, et al. (2009) Transforming growth factor beta1 signaling via interaction with cell surface Hyal-2 and recruitment of WWOX/WOX1. J Biol Chem 284: 16049-16059.
54. Baker K, Raut P, Jass JR, (2007) Microsatellite unstable colorectal cancer cell lines with truncating TGFbetaRII mutations remain sensitive to endogenous TGFbeta. The Journal of Pathology 213: 257-265.
55. Ilyas M, Efstathiou JA, Straub J, Kim HC, Bodmer WF, (1999) Transforming growth factor beta stimulation of colorectal cancer cell lines: type II receptor bypass and changes in adhesion molecule expression. Proc Natl Acad Sci U S A 96: 3087-3091.
56. Saxena A, Raveh L, Ashani Y, Doctor BP, (1997) Structure of glycan moieties responsible for the extended circulatory life time of fetal bovine serum acetylcholinesterase and equine serum butyrylcholinesterase. Biochemistry 36: 7481-7489.
57. Egrie JC, Dwyer E, Browne JK, Hitz A, Lykos MA, (2003) Darbepoetin alfa has a longer circulating half-life and greater in vivo potency than recombinant human erythropoietin. Experimental Hematology 31: 290-299.
58. Moro L, Perlino E, Marra E, Languino LR, Greco M, (2004) Regulation of beta1C and beta1A integrin expression in prostate carcinoma cells. J Biol Chem 279: 1692-1702.
59. Wang L, Liang Y, Li Z, Cai X, Zhang W, et al. (2007) Increase in beta1-6 GlcNAc branching caused by N-acetylglucosaminyltransferase V directs integrin beta1 stability in human hepatocellular carcinoma cell line SMMC-7721. Journal of Cellular Biochemistry 100: 230-241.
60. Park SY, Lee SH, Kawasaki N, Itoh S, Kang K, et al. (2011) alpha1-3/4 fucosylation at Asn 241 of beta-haptoglobin is a novel marker for colon cancer: A combinatorial approach for development of glycan biomarkers. International Journal of Cancer 130: 2366-2376.